ArticleOncotarget2017

Clinical outcomes of WBRT plus EGFR-TKIs versus WBRT or TKIs alone for the treatment of cerebral metastatic NSCLC patients: a meta-analysis.

Hong Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.